Concepedia

D Y Liu

DY

Statistics

Publications

1

Citations

11

H-Index

1

Active since

2024

Affiliations

China National Pharmaceutical Group Corporation (China)(Current)

D Y Liu is an author at China National Pharmaceutical Group Corporation (China) specializing in solid tumor car t-cell therapy, immunotherapy, and tumor antigens.

ORCID

Publications per year

2024–2024

1

Publications

1

Antigen-independent activation is critical for the durable antitumor effect of GUCY2C-targeted CAR-T cells

Changsong Qi, D Y Liu, Chang Liu et al. · Journal for ImmunoTherapy of Cancer · 2024 · 11 citations · Full text

, , +17

1–1 of 1